No Data
No Data
No Data
Integral Corporation Partners With Granite Asia for Growth Investment Expansion
Even with the start of the new fiscal year, active buying of leading stocks is likely to continue to be restrained.
This week, trading will primarily focus on short-term investments in bio-related stocks and IPOs as the new fiscal year begins. However, due to the implementation of additional tariffs by the US on April 2, along with strong concerns about the subsequent impact on the real economy, it is believed that active buying cannot be expected given the prevailing uncertainty. The Emerging Markets, centered on domestic demand, seem to be relatively stable compared to the Main Board market, but there is no feeling that the main indices in the Growth market will rise significantly. The Growth Market 250 Index has narrowed its gains.
Baird Downgrades DoubleVerify, Integral Ad Science on Competitive Pressures
Integral Ad Science Cut to Neutral From Outperform by Baird
Baird Downgrades Integral Ad Science Holdi to Neutral, Lowers Price Target to $9
Integral Ad Science Holdi Analyst Ratings